Could Your TRT Dose Explain Fatigue After Eating?

Viewing This Video Is A Member Exclusive Feature

But you don’t need membership to get Dr. O’Connor’s insight on this topic, it’s in the summary, key takeaways, and related drugs and conditions below.

Want to watch the full video? Join the Health Portal Today.

Join Now

Already a member? Sign In

Timeline

00:00

A 43-year-old man taking 200–250 mg of testosterone weekly asks about post-meal fatigue and sleepiness near testosterone peaks. Dr. O’Connor considers whether the dose is excessive and discusses his preferred balance of dose and injection frequency.

01:42

Dr. O’Connor critiques high-dose testosterone and additional anabolic steroids offered by some clinics. He then recounts an older patient whose inconsistent office injection schedule affected how he felt and produced low levels after a two-week gap.

04:20

The focus shifts to the sustainability of frequent injections and multiple hormonal medications. Dr. O’Connor emphasizes the lowest effective testosterone dose, a manageable long-term regimen, and continued ABCDs™ monitoring.

Video Summary

A 43-year-old man on TRT reports strong fatigue after meals and greater sleepiness when testosterone peaks. He uses 200–250 mg weekly and asks whether his dose could be too high. Dr. O’Connor considers excessive dosing a possibility but does not establish the cause of the fatigue.

Dr. O’Connor describes using 100 mg every five days for himself and many patients as an example of his preferred approach. He emphasizes balancing dose and injection frequency rather than assuming that more testosterone produces better results.

The discussion expands to clinics offering higher testosterone doses and additional anabolic steroids, including Deca-Durabolin and Anavar. Dr. O’Connor questions treatment approaches that accumulate medications without a clear, sustainable plan.

He recounts an older patient who relied on office injections every one or two weeks. The patient reportedly felt better with weekly visits but sometimes delayed treatment, resulting in low testosterone measurements after a two-week interval. The example illustrates how administration timing can affect symptoms and laboratory results.

Dr. O’Connor then questions the long-term practicality of very frequent injections and complex combinations of hormonal medications. He favors the lowest effective testosterone dose, a sustainable schedule, and ongoing monitoring through the ABCDs™ framework. The video does not provide a specific diagnosis or treatment for post-meal fatigue.

Drug Callouts

Testosterone

Testosterone is an androgen hormone used medically to replace deficient testosterone in men with certain forms of hypogonadism. Dr. O’Connor considers whether the questioner’s 200–250 mg weekly dose is excessive and connects dose selection with symptoms, injection timing, and long-term monitoring.

Deca-Durabolin

Deca-Durabolin, or nandrolone decanoate, is an anabolic androgenic steroid related to testosterone that activates androgen receptors and can suppress luteinizing hormone secretion. Dr. O’Connor uses it as an example of an additional steroid offered by some clinics while questioning the expansion of TRT into more complex anabolic drug regimens.

Anavar

Anavar, or oxandrolone, is an oral anabolic steroid that can increase LDL cholesterol and decrease HDL cholesterol. Dr. O’Connor discusses its use alongside testosterone and Deca-Durabolin as part of his critique of clinics adding anabolic drugs for complaints such as recovery or shoulder discomfort.

Condition Callouts

Postprandial Fatigue

Postprandial fatigue describes tiredness or lack of energy after eating; fatigue is a symptom rather than a diagnosis and can have multiple causes. In this man on TRT, Dr. O’Connor considers excessive testosterone exposure because the man also reports sleepiness near hormone peaks, but the discussion does not establish that testosterone causes his symptoms.

Key Takeaways

Fatigue after eating does not identify its cause, and its occurrence during TRT does not by itself prove that testosterone is responsible.
A weekly testosterone dose of 200–250 mg may be excessive for some men, so Dr. O’Connor emphasizes individual dose assessment rather than treating that range as appropriate for everyone.
Symptoms that recur near testosterone peaks or before the next injection provide useful timing information to review alongside consistently timed laboratory results.
Delayed or inconsistent injections can change testosterone exposure and make symptoms and laboratory results harder to compare.
Adding anabolic steroids introduces additional effects and risks; oxandrolone, for example, can raise LDL cholesterol and lower HDL cholesterol.
A sustainable TRT plan should use the lowest effective dose, a schedule the patient can maintain, and ongoing health monitoring rather than continually adding injections or medications.